- Koninklijke DSM is among suitors exploring potential bids for DuPont's (DD -0.5%) nutrition and bioscience business, which could be valued at as much as $25B, Bloomberg reports.
- In addition to Royal DSM (OTCQX:RDSMY), DuPont also has reached out to other potential bidders including Ireland's Kerry Group (OTCPK:KRYAY) and Swiss fragrances and flavorings maker Givaudan (OTCPK:GVDBF), according to the report.
- DuPont reportedly recently sent confidentiality agreements to prospective buyers and hopes to conclude the review by the end of the year.